Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Depreciation and Depletion (2022 - 2025)

Prokidney (PROK) has disclosed Depreciation and Depletion for 4 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion rose 16.6% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.6 million, a 45.14% increase, with the full-year FY2024 number at $4.3 million, up 46.72% from a year prior.
  • Depreciation and Depletion was $1.4 million for Q3 2025 at Prokidney, down from $1.5 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.5 million in Q2 2025 to a low of $593000.0 in Q1 2022.
  • A 4-year average of $934333.3 and a median of $832000.0 in 2024 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: grew 5.56% in 2023, then surged 66.35% in 2025.
  • Prokidney's Depreciation and Depletion stood at $623000.0 in 2022, then skyrocketed by 39.97% to $872000.0 in 2023, then surged by 53.78% to $1.3 million in 2024, then grew by 4.25% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Depreciation and Depletion are $1.4 million (Q3 2025), $1.5 million (Q2 2025), and $1.4 million (Q1 2025).